Clinical trial Recruiting at 2 sites Interventional Ages 65 and up

Dance therapy for seniors with dementia symptoms

Official title: Dance Workshop for Institutionalized Seniors With Behavioral and Psychological Symptoms of Dementia

Run by Centre Hospitalier Emile Roux · NCT05799001 · Data updated 2026-11-12

This study tests if dance therapy can help seniors with dementia feel better and improve their daily activities.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment180 (estimated)
SponsorCentre Hospitalier Emile Roux
Academic / other
Locations2 sites (Craponne-sur-Arzon and 1 other locations)
StatusRecruiting
StartedMarch 8, 2023
Main results expectedJanuary 31, 2026
Study endsJuly 31, 2026
Registry record updatedAugust 7, 2025
Trial IDNCT05799001 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are institutionalized individuals over 65 years old with measurable behavioral problems related to dementia.

Probably not a fit

Patients unable to participate in dance sessions due to severe disabilities or concurrent psychiatric disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study explores the effects of dance therapy on institutionalized seniors experiencing behavioral and psychological symptoms of dementia. It aims to assess whether engaging in dance can reduce these symptoms and improve daily living activities. Participants will be evaluated using the Neuropsychiatric Inventory (NPI) to measure changes in their behavioral issues. The intervention is designed for seniors who can mobilize their upper body and have stable medication regimens.

Why it matters

Potential benefit: If successful, this approach could significantly alleviate behavioral symptoms in seniors with dementia, enhancing their quality of life.

How similar studies have gone: Previous studies have indicated that physical activity, including dance, can effectively reduce behavioral symptoms in dementia patients, suggesting a promising avenue for this intervention.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Institutionalized patient (male or female) over 65 years of age ;
2. Patient with behavioral problems, as measured by an NPI-ES ≥ 4 on any item and an NPI-ES impact scale ≥ 3 ;
3. Patient able to mobilize the upper body at a minimum (arms, trunk, head);
4. Medication (antipsychotics, antidepressants, anxiolytics and related hypnotics) without major modification for at least 30 days prior to inclusion after medical advice;
5. Possibility of including patients under guardianship or curatorship;
6. Patient affiliated to a social security plan;
7. Obtaining consent from the patient or legal representative.

   Exclusion Criteria:
8. Inability of the patient to follow the sessions (e.g., major visual/auditory disabilities), difficult follow-up, or any other reason at the discretion of the investigator;
9. Inability of the health care team to complete the NPI-ES questionnaire for the patient;
10. Patient has a concurrent psychiatric disorder (e.g., bipolar disorder, schizophrenia, or other).

Where it's running

  • Centre Hospitalier Pays Craponne
    Craponne-sur-Arzon, France
    Recruiting
  • Centre Hospitalier Emile Roux
    Le Puy-en-Velay, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.